Founded 2007 by Jan Mikael Nordfors MD, only for informational purposes. Shall not replace the advice of a skilled therapist.
You are here
Items per page
Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse
The Mikael Nordfors site operates under a Creative Commons License
Copyright © 2018,